Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial

Nobuhisa Hagiwara(Tokyo Women's Medical University), Hiroshi Ogawa(Kumamoto University), Kunihiko Matsui(Kumamoto University), Yasuhiro Endoh(Saiseikai Ibaraki Hospital), Erisa Kawada‐Watanabe(Tokyo Women's Medical University), Junichi Yamaguchi(Tokyo Women's Medical University), Ryo Koyanagi(Tokyo Women's Medical University), Kōichi Nakao(Kanazawa Seiryo University), Tatsuro Uchida(Sendai Medical Center), Hiroyuki Tanaka(Tokyo Metropolitan Tama Medical Center), Kozue Saito, Hiroyuki Arashi(Tokyo Women's Medical University), Toshiaki Oka(Seirei Hamamatsu General Hospital), Tetsuya Tobaru(Sakakibara Hospital)
European Heart Journal
March 14, 2017
10.1093/eurheartj/ehx162
Cited by 134

Related Papers

Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|848
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2015|453